A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas (Q73119226)
Jump to navigation
Jump to search
scientific article published on 01 November 2000
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas |
scientific article published on 01 November 2000 |
Statements
A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas (English)
F R Appelbaum
1 reference
J F Eary
T Gooley
S Liu
J G Rajendran
D G Maloney
S Petersdorf
S A Bush
L D Durack
P J Martin
D R Fisher
B Wood
J W Borrow
B Porter
J P Smith
D C Matthews
I D Bernstein
1 November 2000